The Protective Effect of Dabigatran and Rivaroxaban on DNA Oxidative Changes in a Model of Vascular Endothelial Damage with Oxidized Cholesterol
Background: Atherosclerotic plaques are unstable, and their release may result in thrombosis; therefore, currently, antiplatelet therapy with anticoagulants is recommended for the treatment of acute coronary syndrome. The aim of this study was to assess the effect of oxidized cholesterol on human um...
Main Authors: | Ewelina Woźniak, Marlena Broncel, Bożena Bukowska, Paulina Gorzelak-Pabiś |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/6/1953 |
Similar Items
-
The protective effects of empagliflozin on DNA oxidative changes in a model of vascular endothelial and smooth muscle cells damaged by oxidized cholesterol
by: Ewelina Woźniak, et al.
Published: (2024-01-01) -
Comparative Effectiveness and Safety of Dabigatran and Rivaroxaban in Atrial Fibrillation Patients
by: Chao‐Lun Lai, et al.
Published: (2017-04-01) -
A review of pharmacogenetics of anticoagulant therapy: Heparins, rivaroxaban, apixaban, and dabigatran
by: Ali Mohammed Abd Alridha, et al.
Published: (2022-01-01) -
Effects of direct oral anticoagulants dabigatran and rivaroxaban on the blood coagulation function in rabbits
by: Yin Lu, et al.
Published: (2022-01-01) -
The Effects of Dabigatran and Rivaroxaban on Markers of Polymorphonuclear Leukocyte Activation
by: Guy A. Richards, et al.
Published: (2018-05-01)